On Tuesday, BioMarin Pharmaceutical CEO Jean-Jacques Bienaime appeared on “Mad Money” to talk about how his company develops and commercializes pharmaceutical products for lysosomal storage disorders.
Speaking with host Jim Cramer, Bienamie discussed the different drugs the company has on the market, as well as what’s to come. He also addressed the biotechnology space in general.
Watch the video to see the full interview.
Call Cramer: 1-800-743-CNBC
Questions for Cramer? firstname.lastname@example.org
Questions, comments, suggestions for the Mad Money website? email@example.com